Refined atrial fibrillation screening and cost-effectiveness in the German population

Conclusions
In our middle-aged population cohort, we identified 0.2% new AF by single timepoint screening. There was a significant estimated risk of stroke and heart failure in these individuals. Cost-effectiveness for screening may be reached in individuals aged 65 years and older. The simple age cut-off is not improved by using Nt-proBNP as a biomarker to guide a screening programme.

Source: Heart - February 24, 2022 Category: Cardiology Authors: Schnabel, R. B., Wallenhorst, C., Engler, D., Blankenberg, S., Pfeiffer, N., Spruenker, N. A., Buettner, M., Michal, M., Lackner, K. J., Münzel, T., Wild, P. S., Martinez, C., Freedman, B., Gutenberg Health Study investigators Tags: Open access Cardiac risk factors and prevention Source Type: research